OMAR FULLER: Open Payments
NPI 1932833050 · LOGANVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 17 payments from 6 companies in 2025. Trend: 2023 $382 · 2024 $1,204 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $352 |
| E.R. Squibb & Sons, L.L.C. | 1 | $129 |
| Neurocrine BioSciences, Inc. | 3 | $96 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: UZEDY, COBENFY, INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across GA — which companies pay providers there.
